Clinical Unit definition

Clinical Unit means the employee's immediate work area.
Sample 1Sample 2Sample 3
Clinical Unit means for the purpose of these definitions an area of nursing practice as agreed between the parties, and without limiting the foregoing shall include an area or place of nursing practice with a resident/client population.
Sample 1Sample 2
Clinical Unit means for the purposes of these definitions an area of nursing practice and, without limiting the foregoing, shall include a ward, area or place of nursing practise with a patient/client population.
Sample 1Sample 2Sample 3

Examples of Clinical Unit in a sentence

  • NOTE: An MS4 Clinical Unit is equal to at least four weeks and counts as one elective/selective credit regardless if four weeks in duration or up to 16 weeks duration.

  • Each Clinical Unit has added a project to improve the quality of Medical Records to their project plans.

  • In study period, the subjects will be admitted to the FARMAGEN Clinical Unit in the evening (18:00) prior to morning of the administration of medication after screening and isolation period as described in Appendix VII.

  • Students must discuss any non-attendance and deficit in placement hours with the Clinical Unit of Study Coordinator, who will then liaise with the Clinical Learning Office about individual students’ make up requirements.

  • Subjects will be admitted to the Early Phase Clinical Unit (EPCU) on Day -1, and will be confined to the EPCU until discharge on Day 8.

  • WCDSS' Clinical Unit has a contracted Psychiatrist, who provides Medical Oversight to its Behavioral Health Community Network (BHCN -Provider Type 14) while the PLR Unit contracts with two psychiatrists to conduct chart reviews of children prescribed psychotropic medications.• Goal: WCDSS will hold a refresher course on the Medical Home model for agency staff.

  • Both partners must inform the Clinical Unit Leader who will be working the predetermined schedule according to the posting policies for schedules.

  • The Nephrology Unit reports to the Division of Medicine and Therapeutic Services, led by Dr. Melanie Hiorns as Clinical Unit Chair and Ms. Anna Jebb as General Manager.

  • Academic (continued): University of Miami Project Leader, Miami Unit 1996-1999 Developing Minority Biomedical Research Talent in Psychology APA/NIGMS Multi-Center Training Grant University of Miami Project Manager/Investigator 1995-2002 Miami Clinical Unit of Multi-Center Clinical Trial, Enhancing Recovery in CHD Patients (N01-HC55143).

  • Drug resistance testing for collaborative studies involved samples CHAPAS, ARROW and DART; these are all UK Medical Research Council and AIDS Clinical Unit collaborative projects.


More Definitions of Clinical Unit

Clinical Unit means a Thermage Generator or Thermage Disposable Device intended for use in clinical trials.
Sample 1Sample 2Sample 3
Clinical Unit means an area of nursing practice, as agreed between the parties, and without limiting the foregoing shall include a xxxx, area or place of nursing practice with a patient/client population.
Sample 1Sample 2
Clinical Unit means the employee’s immediate work area, howsoever named.
Sample 1
Clinical Unit means (a) one (1) tablet of Product intended by Salix to be used in pre-clinical or clinical studies and not for commercial sale (an “Active Clinical Unit”) and (b) one (1) placebo tablet that corresponds to an Active Clinical Unit and is intended by Salix to be used in pre-clinical or clinical studies and not for commercial sale (a “Placebo Unit”).
Sample 1

Related to Clinical Unit

  • Clinical peer means a physician or other health care professional who holds a non-restricted license in a state of the United States and in the same or similar specialty as typically manages the medical condition, procedure or treatment under review.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Clinical Trial means any human clinical trial of a Product.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Pre-Licensed Therapist means an individual who has obtained a Master’s Degree in Social Work or Marriage and Family Therapy and is registered with the BBS as an Associate CSW or MFT Intern acquiring hours for licensing. An individual’s registration is subject to regulations adopted by the BBS.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Participating Product means any of the Breville products listed in the table below by model name and number that are supplied by Breville in Australia and sold directly by Breville or by a Participating Retail Store:

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • clinical investigation means any systematic investigation in one or more human subjects, undertaken to assess the safety or performance of a device;

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.